Search

Your search keyword '"Joseph Odin"' showing total 8 results
Start Over "Joseph Odin" Publisher comtex news network, inc.
8 results on '"Joseph Odin"'

1. CymaBay Therapeutics Presents New Findings that Seladelpar Treatment of PBC Patients for Two Years Predicts Improved Transplant-Free Survival

Subjects
Medical research, Medicine, Experimental, Chronic diseases -- Patient outcomes, Liver, College teachers, Gastrointestinal diseases -- Patient outcomes, Evidence-based medicine, Banking, finance and accounting industries, Business
Abstract

NEWARK, May 23, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:CBAY), EQNX::TICKER_END CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for [...]

Published
2022

2. CymaBay Therapeutics Announces Presentations at Digestive Disease Week(R) 2022

Subjects
Chronic diseases, Liver, Gastrointestinal diseases, Evidence-based medicine, Banking, finance and accounting industries, Business
Abstract

NEWARK, May 11, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:CBAY), EQNX::TICKER_END CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for [...]

Published
2022

3. CymaBay Therapeutics Presents Positive PBC Data at the International Liver Congress(TM) 2021

Subjects
United States. Food and Drug Administration -- Political activity, Medical research -- Political aspects, Medicine, Experimental -- Political aspects, Chronic diseases -- Political aspects, Liver -- Political aspects, Evidence-based medicine -- Political aspects, Banking, finance and accounting industries, Business
Abstract

NEWARK, Jun 21, 2021 (GLOBE NEWSWIRE via COMTEX) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Published
2021

4. CymaBay Therapeutics Announces Presentations During The International Liver Congress(TM) 2021

Subjects
Chronic diseases -- Political aspects, Liver -- Political aspects, Evidence-based medicine -- Political aspects, Liver cirrhosis -- Political aspects, Banking, finance and accounting industries, Business
Abstract

NEWARK, Jun 09, 2021 (GLOBE NEWSWIRE via COMTEX) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Published
2021

6. CymaBay Therapeutics Announces Presentations at The Liver Meeting(R) 2019

Subjects
Liver diseases, Medical research, Liver, Banking, finance and accounting industries, Business
Abstract

NEWARK, Calif., Oct 01, 2019 (GLOBE NEWSWIRE via COMTEX) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY) today announced that two abstracts related to its seladelpar development program for the treatment of primary [...]

Published
2019

7. CymaBay Therapeutics Announces Multiple Presentations at DDW 2019

Subjects
Gastrointestinal diseases, Digestive system diseases, Banking, finance and accounting industries, Business
Abstract

NEWARK, May 08, 2019 (GLOBE NEWSWIRE via COMTEX) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that multiple abstracts related to its seladelpar clinical development program for the treatment of [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results